Absolutely! GLP-1 receptor agonists (GLP-1 RAs) are frequently used in the treatment of type 2 diabetes because they help improve control of blood glucose and cause weight reduction as well. These medications facilitate glycemic control by improving insulin secretion, reducing glucagon response, and decreasing the rate at which food leaves the stomach which all together help to control glucose levels after eating.

Weight loss is especially important for people who have type 2 diabetes, as it can enable them to develop a greater metabolic health. A decrease in weight of between 5-10% has shown to improve one’s sensitivity to insulin and control blood sugar levels. Such an improvement can in some cases, allow blood sugar levels to return to the normal range thus decreasing or fully removing the need for diabetic treatment including insulin consumption.

In some cases, patients who lose significant amounts of weight may achieve a state of remission where their diabetes is not active, meaning that they do not have to use medications to keep their blood glucose levels stable. This is particularly important as remission may help in preventing diabetes complications such as cardiovascular diseases, neuropathy, and kidney diseases.

Nations across the world have approved pharmaceutical grade liraglutide, semaglutide as well as dulaglutide as these are great in lowering both, the levels of HbA1c and the weight of the client. Such medications are really helpful in managing diabetes for those who are overweight or obese, making its application two-folds; improving blood sugar control as well as managing one’s weight.

Majority of the diabetes guidelines recommend the usage of GLP-1 RAs for individuals with type 2 diabetes who are obese or find it hard to lose weight as it would keep the condition under control. In this scenario, the consequences of taking insulin or other weight gain medications become negligible thereby increasing the chance of a healthy post long-term treatment.